Filtered By:
Condition: Atrial Fibrillation
Management: Hospitals
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 621 results found since Jan 2013.
Establishing minimally invasive cardiac surgery in a low-volume mitral surgery centre
DISCUSSION: It is possible for low-volume cardiac surgical centres to undertake minimally invasive surgical programmes with good outcomes and short learning curves. Despite technical complexities, with a team approach, the learning curve can be navigated safely.PMID:34058117 | DOI:10.1308/rcsann.2020.7092
Source: Annals of the Royal College of Surgeons of England - May 31, 2021 Category: Surgery Authors: B H Kirmani A Knowles P Saravanan J Zacharias Source Type: research
Wearable devices show that physical activity may lower atrial fibrillation and stroke risk
(Massachusetts General Hospital) Guideline-adherent exercise is shown in a large study to be associated with substantially lower risks of atrial fibrillation and stroke. A new generation of " smart " devices with diagnostic capabilities could open the door to low-cost, highly effective disease prevention programs.
Source: EurekAlert! - Medicine and Health - May 25, 2021 Category: International Medicine & Public Health Source Type: news
Pericardial Effusion Requiring Intervention in Patients Undergoing Percutaneous Left Atrial Appendage Occlusion: Prevalence, Predictors and Associated In-hospital Adverse Events from 17,700 Procedures in the United States
Left atrial appendage occlusion has shown promise in mitigating risk of stroke in selected patients with atrial fibrillation.
Source: Heart Rhythm - May 17, 2021 Category: Cardiology Authors: Muhammad Bilal Munir, Muhammad Zia Khan, Douglas Darden, Deepak Kumar Pasupula, Sudarshan Balla, Frederick T. Han, Ryan Reeves, Jonathan C. Hsu Source Type: research
Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients with PAD ...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Antithrombotic treatment management in low stroke risk patients undergoing cardioversion of atrial fibrillation & lt;48 h duration: results of an EHRA survey
AbstractData supporting the safety of cardioversion (CV) of atrial fibrillation (AF) without anticoagulation in patients with AF duration<48 h are scarce. Observational studies suggest that the risk of stroke in these patients is very low when the definite duration of the AF episode is of<48 h and the clinical risk profile as estimated through the CHA2DS2VASc score is low (a score of 0 for men and 1 for women). As the recent 2020 European Society of Cardiology (ESC) guidelines indication for this clinical scenario is based mainly on consensus, we sent out a survey to assess the current clinical practice on anti...
Source: Europace - May 15, 2021 Category: Cardiology Source Type: research
Single-Dose del Nido Cardioplegia Compared With Standard Cardioplegia During Coronary Artery Bypass Grafting at a Veterans Affairs Hospital
Tex Heart Inst J. 2021 Jan 1;48(1):e196981. doi: 10.14503/THIJ-19-6981.ABSTRACTDel Nido cardioplegic solution (DNC), used chiefly in pediatric patients, rapidly induces prolonged cardiac arrest during cardiac surgery. To determine whether surgical outcomes after coronary artery bypass grafting in a United States military veteran population differed when DNC was used instead of our standard Plegisol cardioplegia, we retrospectively reviewed 155 consecutive operations performed from July 2016 through June 2017. Del Nido cardioplegia was used to induce cardiac arrest in 70 patients, and Plegisol in 85. Compared with the Plegi...
Source: Texas Heart Institute Journal - May 4, 2021 Category: Cardiology Authors: Michael R Reidy Ernesto Jimenez Shuab Omer Lorraine D Cornwell Sabrina X Runbeck Ourania Preventza Gabriel Loor Todd K Rosengart Joseph S Coselli Source Type: research
